Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis – a Paradoxical Effect of the

Research Article BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental

Autoimmune Encephalomyelitis
Sofia Fern
A Gonçalves Zorzella-pezavento
Clara Pires Fujiara Guerino
A Chiuso-minicucci
Thais Graziela Donegá França
Alexandrina Sartori

August 2016

Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

brandt, l
cunha, jf
olsen, aw
chilima, b
hirsch, p
appelberg, r
andersen, p

January 2002

The efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine against pulmonary tubercu...

Image_1_Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.TIF

Yaqi Wu (4455664)
Ming Cai (342151)
Jilei Ma (5906888)
Xindong Teng (714723)
Maopeng Tian (4890934)
Eman Borham Mohamed Borham Bassuoney (5906891)
Xionglin Fan (366861)

October 2018

Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an ef...

Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis - a Paradoxical Effect of the Vector?

Pelizon, A. C.
Martins, D. R.
Zorzella-Pezavento, S. F. G.
Seger, J.
Justulin, L. A.
da Fonseca, D. M.
Santos, R. R.
Masson, A. P.
Silva, C. L.
Sartori, Alexandrina

February 2010

A new tuberculosis vaccine is urgently needed. Prime-boost strategies are considered very promising ...

BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines

Foster, M.
Hill, P.C.
Setiabudiawan, T.P.
Koeken, V.A.C.M.
Alisjahbana, B.
Crevel, R. van

January 2021

Item does not contain fulltextThe tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was intro...

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study

Fletcher, H
Filali-Mouhim, A
Nemes, E
Hawkridge, A
Keyser, A
Njikan, S
Hatherill, M
Scriba, T
Abel, B
Kagina, B
Veldsman, A
Agudelo, N
Kaplan, G
Hussey, G
Sekaly, R
Hanekom, W
BCG study team

January 2016

Background An incomplete understanding of the immunological mechanisms underlying protection against...

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

Rook, GAW
Dheda, K
Zumla, A

March 2005

Tuberculosis vaccine candidates are entering clinical studies in areas where BCG fails. This is a hi...

Diagnostic biomarkers and improved vaccination against mycobacterial infection

Rahman, Muhammad Jubayer

January 2008

Tuberculosis (TB) remains one of the world’s most serious infectious diseases. It is estimated that ...

How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis?

Parkash, Om

March 2014

AbstractBacillus Calmette–Guérin (BCG) remains the only widely used vaccine against tuberculosis (TB...

The influence of BCG vaccine strain on the immune response and protection against tuberculosis

RITZ, NICOLE

January 2009

BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis

Goncalves Zorzella-Pezavento, Sofia Fernanda
Fujiara Guerino, Clara Pires
Chiuso-Minicucci, Fernanda
Donega Franca, Thais Graziela
Watanabe Ishikawa, Larissa Lumi
Masson, Ana Paula
Silva, Celio Lopes
Sartori, Alexandrina

January 2013

A prime-boost strategy conserving BCG is considered the most promising vaccine to control tuberculos...

Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda

Lule, Swaib Abubaker
Mawa, Patrice
Nkurunungi, Gyaviira
Nampijja, Margaret
Kizito, Dennison
Akello, Florence
Muhangi, Lawrence
Elliott, Alison
Webb, Emily L

December 2014

BCG is used widely as the sole licensed vaccine against tuberculosis, but it has variable efficacy a...

Vaccination against tuberculosis: how can we better BCG?

Pitt, JM
Blankley, S
McShane, H
O'Garra, A

May 2013

Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...

Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis

Souza, Patrícia R M
Zárate-Bladés, Carlos R
Hori, Juliana I
Ramos, Simone G
Lima, Deison S
Schneider, Tatiana
Rosada, Rogério S
Torre, Lucimara G L
Santana, Maria Helena A
Brandão, Izaíra T
Masson, Ana P
Coelho-Castelo, Arlete A M
Bonato, Vânia L
Galetti, Fabio C S
Gonçalves, Eduardo D
Botte, Domingos A
Machado, Jeanne B M
Silva, Celio L

June 2020

Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming

Gonçalves, Eduardo DC
Bonato, Vânia
da Fonseca, Denise M
Soares, Edson G
Brandão, Izaíra T
Soares, Ana
Silva, Célio L

January 2007

Vaccines are considered by many to be one of the most successful medical interventions against infec...

Research Article BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental

Autoimmune Encephalomyelitis
Sofia Fern
A Gonçalves Zorzella-pezavento
Clara Pires Fujiara Guerino
A Chiuso-minicucci
Thais Graziela Donegá França
Alexandrina Sartori

August 2016

Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

brandt, l
cunha, jf
olsen, aw
chilima, b
hirsch, p
appelberg, r
andersen, p

January 2002

The efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine against pulmonary tubercu...

Image_1_Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.TIF

Yaqi Wu (4455664)
Ming Cai (342151)
Jilei Ma (5906888)
Xindong Teng (714723)
Maopeng Tian (4890934)
Eman Borham Mohamed Borham Bassuoney (5906891)
Xionglin Fan (366861)

October 2018

Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an ef...

Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis - a Paradoxical Effect of the Vector?

Pelizon, A. C.
Martins, D. R.
Zorzella-Pezavento, S. F. G.
Seger, J.
Justulin, L. A.
da Fonseca, D. M.
Santos, R. R.
Masson, A. P.
Silva, C. L.
Sartori, Alexandrina

February 2010

A new tuberculosis vaccine is urgently needed. Prime-boost strategies are considered very promising ...

BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines

Foster, M.
Hill, P.C.
Setiabudiawan, T.P.
Koeken, V.A.C.M.
Alisjahbana, B.
Crevel, R. van

January 2021

Item does not contain fulltextThe tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was intro...

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study

Fletcher, H
Filali-Mouhim, A
Nemes, E
Hawkridge, A
Keyser, A
Njikan, S
Hatherill, M
Scriba, T
Abel, B
Kagina, B
Veldsman, A
Agudelo, N
Kaplan, G
Hussey, G
Sekaly, R
Hanekom, W
BCG study team

January 2016

Background An incomplete understanding of the immunological mechanisms underlying protection against...

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

Rook, GAW
Dheda, K
Zumla, A

March 2005

Tuberculosis vaccine candidates are entering clinical studies in areas where BCG fails. This is a hi...

Diagnostic biomarkers and improved vaccination against mycobacterial infection

Rahman, Muhammad Jubayer

January 2008

Tuberculosis (TB) remains one of the world’s most serious infectious diseases. It is estimated that ...

How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis?

Parkash, Om

March 2014

AbstractBacillus Calmette–Guérin (BCG) remains the only widely used vaccine against tuberculosis (TB...

The influence of BCG vaccine strain on the immune response and protection against tuberculosis

RITZ, NICOLE

January 2009

BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis

Goncalves Zorzella-Pezavento, Sofia Fernanda
Fujiara Guerino, Clara Pires
Chiuso-Minicucci, Fernanda
Donega Franca, Thais Graziela
Watanabe Ishikawa, Larissa Lumi
Masson, Ana Paula
Silva, Celio Lopes
Sartori, Alexandrina

January 2013

A prime-boost strategy conserving BCG is considered the most promising vaccine to control tuberculos...

Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda

Lule, Swaib Abubaker
Mawa, Patrice
Nkurunungi, Gyaviira
Nampijja, Margaret
Kizito, Dennison
Akello, Florence
Muhangi, Lawrence
Elliott, Alison
Webb, Emily L

December 2014

BCG is used widely as the sole licensed vaccine against tuberculosis, but it has variable efficacy a...

Vaccination against tuberculosis: how can we better BCG?

Pitt, JM
Blankley, S
McShane, H
O'Garra, A

May 2013

Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...

Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis

Souza, Patrícia R M
Zárate-Bladés, Carlos R
Hori, Juliana I
Ramos, Simone G
Lima, Deison S
Schneider, Tatiana
Rosada, Rogério S
Torre, Lucimara G L
Santana, Maria Helena A
Brandão, Izaíra T
Masson, Ana P
Coelho-Castelo, Arlete A M
Bonato, Vânia L
Galetti, Fabio C S
Gonçalves, Eduardo D
Botte, Domingos A
Machado, Jeanne B M
Silva, Celio L

June 2020

Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming

Gonçalves, Eduardo DC
Bonato, Vânia
da Fonseca, Denise M
Soares, Edson G
Brandão, Izaíra T
Soares, Ana
Silva, Célio L

January 2007

Vaccines are considered by many to be one of the most successful medical interventions against infec...

Research Article BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental

Autoimmune Encephalomyelitis
Sofia Fern
A Gonçalves Zorzella-pezavento
Clara Pires Fujiara Guerino
A Chiuso-minicucci
Thais Graziela Donegá França
Alexandrina Sartori

August 2016

Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

brandt, l
cunha, jf
olsen, aw
chilima, b
hirsch, p
appelberg, r
andersen, p

January 2002

The efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine against pulmonary tubercu...

Image_1_Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.TIF

Yaqi Wu (4455664)
Ming Cai (342151)
Jilei Ma (5906888)
Xindong Teng (714723)
Maopeng Tian (4890934)
Eman Borham Mohamed Borham Bassuoney (5906891)
Xionglin Fan (366861)

October 2018

Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an ef...

Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis – a Paradoxical Effect of the

Abstract

Extracted data

Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis – a Paradoxical Effect of the

Abstract

Extracted data

Related items

Related items